Evaluation of Immunoassay Measurements of Pancreatic Stone Protein Performed on abioSCOPE® Device With the PSP Assay on ICU Patients at Risk of Sepsis as an Aid in Identifying Sepsis

Inclusion Criteria: * 1\. Provision and understanding of signed and dated written informed consent by patient or legally designated representative prior to any mandatory study-specific procedures, sample collection, or analysis. * 2\. Male or female, aged ≥ 18 years. * 3\. Admitted to ICU on the day of screening, with expectation that patient will require ICU management for a minimum of 24 hours. Exclusion Criteria: * 1\. Expected to die within 24 hours no matter what therapy is given, from the time of screening. * 2\. Suffering on ICU admission or study entry from or known acute or chronic pancreatitis or pancreatic cancer). * 3\. Admitted to ICU due to elective cardiac surgery with an uncomplicated stay anticipated. * 4\. Patients having a valid Do Not Resuscitate order. * 5\. Previous ICU admission during this hospital stay * 6\. Confirmed COVID-19 as reason for ICU admission